Schizophrenia Trials

SND11

SND11 Adolescent Schizophrenia Study

The Adolescent Schizophrenia Study is a late (IIb/III) phase clinical study to examine the safety and efficacy of an investigational therapy named NaBen® in improving the symptoms of schizophrenia among teenagers.  

Status: Actively Recruiting

SND12

SND12 Refractory Schizophrenia Study

The Refractory Schizophrenia Study is a late (IIb/III) phase clinical study to examine the safety and efficacy of an investigational therapy named NaBen® in improving the symptoms of schizophrenia among adults who did not respond to at least 2 current drug treatment and is currently receiving Clozapine.  

Status: Actively Recruiting

SND13

SND13 Adult Schizophrenia Study

The Adult Schizophrenia Study is a late (IIb/III) phase clinical study to examine the safety and efficacy of an investigational therapy named NaBen® in improving the symptoms of schizophrenia among adults between 18 and 45 years old.

 

Status: Actively Recruiting